课题基金 / 基金详情

A multicentre randomised controlled trial of probiotic and peanut oral immunotherapy for the treatment of peanut allergy

A multicentre randomised controlled trial of probiotic and peanut oral immunotherapy for the treatment of peanut allergy
益生菌和花生口服免疫疗法治疗花生过敏的多中心随机对照试验
批准号:
nhmrc : GNT1105429
负责人:
Dr Wesley Burks
金额:
$288.73万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A curative treatment for food allergy is required to prevent deaths and improve management. We recently trialed a new treatment for peanut allergy that was highly effective. Over 80% of children treated with Probiotic and Peanut Oral ImmunoTherapy (PPOIT) tolerated peanut as compared to 4% of children who received placebo. We now plan a larger multicentre trial to confirm these findings. If successful, we will have established a new treatment for peanut allergy and possibly all food allergies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金